The Rapidly Expanding Group of RB1-Deleted Soft Tissue Tumors: An Updated Review

Sasha Libbrecht1, Jo Van Dorpe1,2, David Creytens1,2

  • 1Department of Pathology, Ghent University Hospital, Ghent University, 9000 Ghent, Belgium.

Insights

RB1-deleted soft tissue tumors are a growing group of neoplasms linked to the Retinoblastoma 1 gene. This review covers their features and differential diagnosis.

Area of Science:

  • Oncology
  • Pathology
  • Genetics

Background:

  • Soft tissue tumor classification has advanced due to understanding tumor pathogenesis.
  • Retinoblastoma 1 (RB1) gene deletion is implicated in specific soft tissue neoplasms.
  • RB1-deleted soft tissue tumors are a rapidly expanding group.

Purpose of the Study:

  • To review the morphological, immunohistochemical, and molecular features of RB1-deleted soft tissue tumors.
  • To emphasize the differential diagnosis of these mesenchymal tumors.

Main Methods:

  • Review of current literature on RB1-deleted soft tissue tumors.
  • Analysis of morphological characteristics.
  • Evaluation of immunohistochemical markers.
  • Assessment of molecular findings.

Main Results:

  • The group includes spindle cell/pleomorphic lipoma, atypical spindle cell/pleomorphic lipomatous tumor, pleomorphic liposarcoma, myofibroblastoma, cellular angiofibroma, and acral fibromyxoma.
  • Most RB1-deleted tumors are benign, primarily affecting older adults.
  • Pleomorphic liposarcoma is an exception, considered malignant.

Conclusions:

  • RB1 deletion defines a heterogeneous group of soft tissue tumors.
  • Understanding these features is crucial for accurate diagnosis and management.
  • Further research may elucidate more about the pathogenesis and classification of these tumors.